產(chǎn)品中心Cell Resources
聯(lián)系我們CONTACT US
400-999-210024小時服務(wù)熱線
SW620 (人結(jié)腸癌細胞) (STR鑒定正確)
貨號：CL-0225
規(guī)格：1×10?cells/T25培養(yǎng)瓶
價格： ￥1600
生長培養(yǎng)基：Leibovitz's L-15＋10% FBS＋1% P/S
產(chǎn)品概述
| 名稱 | SW620 (人結(jié)腸癌細胞) (STR鑒定正確) |
| 別稱 | SW-620; SW 620; SW.620 |
| 種屬 | 人類 |
| 生長特性 | 貼壁細胞 |
| 細胞形態(tài) | 上皮細胞樣 |
| 凍存條件 | 凍存液：55% 基礎(chǔ)培養(yǎng)基+40%FBS+5%DMSO 溫度：液氮 |
| 培養(yǎng)方案A（默認） |
生長培養(yǎng)基:
培養(yǎng)條件:
氣相：空氣，100%, 溫度：37℃
|
| 培養(yǎng)方案B（可選） |
培養(yǎng)條件:
氣相：空氣，95%；CO2，5%, 溫度：37℃
|
| 推薦傳代比例 | 1:3-1:4 |
| 推薦換液頻率 | 2-3次/周 |
| 注意事項 | 1.該細胞推薦使用Leibovitz's L-15培養(yǎng)基進行培養(yǎng)，Leibovitz's L-15不可以通入二氧化碳，會產(chǎn)生細胞毒性；2.如您沒有無二氧化碳的培養(yǎng)箱，可使用DMEM替代Leibovitz's L-15，使用DMEM培養(yǎng)基時即可正常通入5%二氧化碳；3.配套專用培養(yǎng)基默認Leibovitz's L-15配置，如需DMEM配方，請聯(lián)系銷售下單備注更改。 |
| 背景描述 | SW620細胞是從一個51歲男性白人組織中分離得到的，由A·Leibovitz等從一個淋巴結(jié)建株。SW620細胞主要由無絨毛的小園球細胞和雙極細胞組成;SW620細胞僅合成少量癌胚抗原(CEA)，在裸鼠中有高度的致瘤性。 |
| 年齡（性別） | 男性；51歲 |
| 組織來源 | 結(jié)直腸腺癌，來自轉(zhuǎn)移淋巴結(jié) |
| 細胞類型 | 腫瘤細胞 |
| 腫瘤類型 | 腸癌細胞 |
| 生物安全等級 | BSL-1 |
| 倍增時間 | ~20-26 hours |
| 致瘤性 | Yes, in nude mice (Tumors developed within 21 days at 100% frequency (5/5) in nude mice inoculated subcutaneously with 1×10^7 cells). |
| 抗原表達情況 | Blood Type A; Rh+ |
| 基因表達情況 | Carcinoembryonic antigen (CEA) 0.15 ng/10^6 cells/10 days; transforming growth factor alpha; matrilysin. The cells are negative for expression of CSAp (CSAp-) and colon antigen 3, negative. The cells are positive for keratin by immunoperoxidase staining. The line is positive for expression of c-myc, K-ras, H-ras, N-ras, Myb, sis and fos oncogenes. |
| 保藏機構(gòu) | ATCC; CCL-227 ECACC; 87051203 |
STR鑒定
-
STR位點信息
Amelogenin X CSF1PO 13,14 D2S1338 17,24 D3S1358 16 D5S818 13 D7S820 8,9 D8S1179 13 D13S317 12 D16S539 9,13 D18S51 13 D19S433 13 D21S11 30,30.2 FGA 24 PentaD 9,15 PentaE 10 TH01 8 TPOX 11 vWA 16 D6S1043 11,12 D12S391 17 D2S441 10,15 -
STR鑒定圖
-
參考文獻
-
D3S-001, a KRAS G12C inhibitor with rapid target engagement kinetics, overcomes nucleotide cycling and demonstrates robust preclinical and clinical activities(2024/05/08)
作者：Jing Zhang, Sunmin Lim, Mira Yu
期刊：Cancer Discovery
DOI：10.1158/2159-8290.CD-24-0006
影響因子 ：28.200
引用產(chǎn)品：CL-0225
-
Mitochondrial genome transfer drives metabolic reprogramming in adjacent colonic epithelial cells promoting TGFβ1-mediated tumor progression(2024/04/30)
作者：Bingjie Guan, Youdong Liu, Bowen Xie
期刊：Nature Communications
DOI：10.1038/s41467-024-48100-y
影響因子 ：16.600
引用產(chǎn)品：CL-0225
-
Biotin-decorated celastrol-loaded ZIF-8 nanoparticles induce ferroptosis for colorectal cancer therapy(2024/02/29)
作者：Jie Chen, Yan Liu, Yanting You
期刊：MATERIALS & DESIGN
DOI：10.1016/j.matdes.2024.112814
影響因子 ：8.400
引用產(chǎn)品：CL-0225
-
Structural elucidation of an acidic polysaccharide from Citrus grandis ‘Tomentosa’ and its anti-proliferative effects on LOVO and SW620 cells(2019/10/01)
作者：Ruiyi Fan, Yuming Xie, Congyi Zhu
期刊：International Journal of Biological Macromolecules
DOI：10.1016/j.ijbiomac.2019.07.117
影響因子 ：8.200
-
A 3-circular RNA signature as a noninvasive biomarker for diagnosis of colorectal cancer(2019/11/04)
作者：Daoxiong Ye, Sisi Wang, Ying Huang
期刊：Cancer Cell International
影響因子 ：5.800
-
LncRNA-ENST00000543604 exerts a tumor-promoting effect via miRNA 564/AEG-1 or ZNF326/EMT and predicts the prognosis of and chemotherapeutic effect in colorectal cancer.(2022/08/23)
作者：Weimin Wang, Zhen Zhou, Xiaojun Dai
期刊：Frontiers in Oncology
影響因子 ：5.738
引用產(chǎn)品：CL-0225
-
Circ_0011385 knockdown inhibits cell proliferation, migration and invasion, whereas promotes cell apoptosis by regulating miR-330-3p/MYO6 axis in colorectal cancer(2022/01/26)
作者：Jing Wang, Shaobo Ke, Yi Gong
期刊：Biomedical Journal
影響因子 ：5.500
引用產(chǎn)品：164210 164210-50 CL-0096 CL-0144 CL-0223 CL-0225 PM150110 PM150210
-
Raltitrexed as a synergistic hyperthermia chemotherapy drug screened in patient-derived colorectal cancer organoids(2021/8/15)
作者：Lisi Zeng, Quanxing Liao, Haoran Zhao
期刊：Cancer Biology & Medicine
DOI：10.20892/j.issn.2095-3941.2020.0566
影響因子 ：5.500
-
Notum palmitoleoyl-protein carboxylesterase regulates Fas cell surface death receptor-mediated apoptosis via the Wnt signaling pathway in colon adenocarcinoma(2021/8/17)
作者：Hua Gong, Qiang Niu, Yi Zhou
期刊：Bioengineered
DOI：10.1080/21655979.2021.1961657
影響因子 ：4.900
-
Hsa_circ_0003602 Contributes to the Progression of Colorectal Cancer by Mediating the miR-149-5p/SLC38A1 Axis(2022/09/23)
作者：Rong Wu, Shiyu Tang, Qiuxiao Wang
期刊：Gut and Liver
影響因子 ：4.321
引用產(chǎn)品：CL-0225
-
miR-370-3p Alleviates Ulcerative Colitis-Related Colorectal Cancer in Mice Through Inhibiting the Inflammatory Response and Epithelial-Mesenchymal Transition(2022/10/31)
作者：Lianjie Lin, Dongxu Wang, Suxuan Qu
期刊：Drug Design Development and Therapy
影響因子 ：4.319
引用產(chǎn)品：CL-0225
-
Circ_0056618 enhances PRRG4 expression by competitively binding to miR-411-5p to promote the malignant progression of colorectal cancer(2022/08/02)
作者：Bo Zhang, Wenbin Cao, Yang Liu
期刊：MOLECULAR AND CELLULAR BIOCHEMISTRY
DOI：10.1007/s11010-022-04525-x
影響因子 ：4.300
引用產(chǎn)品：164210 164210-50 CL-0096 CL-0144 CL-0223 CL-0225 PM150710 PM151010
-
Overexpression of ZNF169 promotes the growth and proliferation of colorectal cancer cells via the upregulation of ANKZF1(2024/04/23)
作者：Jie Zhang, Ye Wang, Shiyang Hou
期刊：ONCOLOGY REPORTS
影響因子 ：4.200
引用產(chǎn)品：CL-0225
-
MicroRNA?129 inhibits colorectal cancer cell proliferation, invasion and epithelial?to?mesenchymal transition by targeting SOX4(2021/03/24)
作者：Zhiping Chen, Tianyu Zhong, Jinghua Zhong
期刊：Oncol Rep
影響因子 ：4.136
-
Exploring immune evasion of SARS-CoV-2 variants using a pseudotyped system(2024/04/18)
作者：Haixiao Duan, Ershuai Zhang, Ge Ren
期刊：Heliyon
DOI：10.1016/j.heliyon.2024.e29939
影響因子 ：4.000
引用產(chǎn)品：CL-0225
-
The bromodomain and extra-terminal domain inhibitor JQ1 synergistically sensitizes human colorectal cancer cells to topoisomerase I inhibitors through repression of Mre11-mediated DNA repair pathway(2020/09/26)
作者：Linping Lei, Xuqin Xie, Long He
期刊：Investigational New Drugs
DOI：10.1007/s10637-020-01014-0
影響因子 ：3.400
-
CircCSNK1G1 Contributes to the Development of Colorectal Cancer by Increasing the Expression of MYO6 via Competitively Targeting miR-455-3p(2020/10/02)
作者：Xianming Huang, Xiaohua Shen, Lixiang Peng
期刊：Cancer Management and Research
影響因子 ：3.300
-
Sevoflurane inhibits malignant progression of colorectal cancer via hsa_circ_0000231-mediated miR-622(2021/06/28)
作者：Jingpeng Wang, Shuyuan Li, Gaofeng Zhang
期刊：Journal of Biological Research-Thessaloniki
DOI：10.1186/s40709-021-00145-6
影響因子 ：3.300
-
Human β-defensin-1 affects the mammalian target of rapamycin pathway and autophagy in colon cancer cells through long non-coding RNA TCONS_00014506(2024/04/15)
作者：Yuxin Zhao, Yan Cui, Xinhong Li
期刊：World Journal of Gastrointestinal Oncology
影響因子 ：3.000
引用產(chǎn)品：CL-0225
-
NDRG4 sensitizes CRC cells to 5-FU by upregulating DDIT3 expression(2021/9/13)
作者：Ruikai Li, Chenxiang He, Liangliang Shen
期刊：Oncology Letters
影響因子 ：2.900
-
microRNA-4429-5p suppresses the malignant development of colon cancer by targeting matrix metalloproteinase 16(2021/08/26)
作者：Wei Li,?Zhe Song,?Nan Jia
期刊：In Vitro Cellular & Developmental Biology-Animal
DOI：10.1007/s11626-021-00603-4
影響因子 ：2.723
引用產(chǎn)品：CL-0050 CL-0096 CL-0144 CL-0223 CL-0225 PM150710 PM150910 PM151010
-
Integrating TCGA and single-cell sequencing data for colorectal cancer: a 10-gene prognostic risk assessment model(2023/09/13)
作者：Di Lu, Xiaofang Li, Yuan Yuan
期刊：Discover Oncology
DOI：10.1007/s12672-023-00789-x
影響因子 ：2.200
引用產(chǎn)品：CL-0225
-
Bone Morphogenetic Protein 1 Targeting COL1A1 and COL1A2 to Regulate the Epithelial-Mesenchymal Transition Process of Colon Cancer SW620 Cells(2020/03/01)
作者：Xijia Zhu, Xishun Luo, Shiyu Jiang
期刊：Journal of Nanoscience and Nanotechnology
影響因子 ：0.000
引用產(chǎn)品：CL-0225
FAQs
Q：{{item.question}}
A：
產(chǎn)品資料
識別碼示意圖
